Literature DB >> 3908488

Beta-2 microglobulin is an amyloidogenic protein in man.

P D Gorevic, T T Casey, W J Stone, C R DiRaimondo, F C Prelli, B Frangione.   

Abstract

Curvilinear fibrils with the tinctorial properties of amyloid were isolated from a patient with bone and joint involvement complicating chronic dialysis for renal disease. Subunit fractions of 24,000 and 12,000 mol wt were identified after gel filtration under dissociating conditions, the latter containing a significant amount of a dimer of the former. This was confirmed by Edman degradation of each fraction, which yielded the amino terminal sequence of normal human beta-2 microglobulin (B2M) to residues 20 and 30, respectively. The size of the subunit protein (12,000 mol wt) and the amino acid composition make it likely that intact B2M is a major constituent of the fibrils. B2M is thus another example of a low molecular weight serum protein, with a prominent beta-pleated sheet structure, that may adopt the fibrillar configuration of amyloid in certain pathologic states.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908488      PMCID: PMC424400          DOI: 10.1172/JCI112257

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Heavy chain of HLA-A and HLA-B antigens is conformationally labile: a possible role for beta 2-microglobulin.

Authors:  D Lancet; P Parham; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

2.  Physical-chemical properties of beta 2-microglobulin.

Authors:  F A Karlsson
Journal:  Immunochemistry       Date:  1974-03

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin.

Authors:  F Gejyo; T Yamada; S Odani; Y Nakagawa; M Arakawa; T Kunitomo; H Kataoka; M Suzuki; Y Hirasawa; T Shirahama
Journal:  Biochem Biophys Res Commun       Date:  1985-06-28       Impact factor: 3.575

Review 5.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

Review 6.  Manifestations of systemic light chain deposition.

Authors:  R E Randall; W C Williamson; F Mullinax; M Y Tung; W J Still
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

7.  Fractionation of primary amyloid fibrils. Characterization and chemical interaction of the subunits.

Authors:  J B Lian; M Skinner; M D Benson; A S Cohen
Journal:  Biochim Biophys Acta       Date:  1977-03-28

8.  Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A.

Authors:  C C Blake; M J Geisow; S J Oatley; B Rérat; C Rérat
Journal:  J Mol Biol       Date:  1978-05-25       Impact factor: 5.469

9.  Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis.

Authors:  N Talal; H M Grey; N Zvaifler; J P Michalski; T E Daniels
Journal:  Science       Date:  1975-03-28       Impact factor: 47.728

10.  Characterization of human beta2-microglobulin by isoelectric focusing.

Authors:  P W Hall; E S Ricanati; C V Vacca
Journal:  Clin Chim Acta       Date:  1977-05-16       Impact factor: 3.786

View more
  40 in total

Review 1.  Amyloidosis and the respiratory tract.

Authors:  J D Gillmore; P N Hawkins
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

2.  Rare presentation of intestinal amyloidosis with acute intestinal pseudo-obstruction and perforation.

Authors:  S B Ng; I A Busmanis
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

Review 3.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

4.  Complement neoantigen and vitronectin are components of plaques in amyloid AL neuropathy.

Authors:  G L Zanusso; G Moretto; B Bonetti; S Monaco; N Rizzuto
Journal:  Ital J Neurol Sci       Date:  1992-09

5.  Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis.

Authors:  N Miyasaka; K Sato; Y Kitano; M Higaki; K Nishioka; K Ohta
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

6.  Structural modifications of human beta 2 microglobulin treated with oxygen-derived radicals.

Authors:  C Capeillere-Blandin; T Delaveau; B Descamps-Latscha
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

7.  Interactive sequences in the molecular chaperone, human alphaB crystallin modulate the fibrillation of amyloidogenic proteins.

Authors:  Joy G Ghosh; Scott A Houck; John I Clark
Journal:  Int J Biochem Cell Biol       Date:  2007-11-13       Impact factor: 5.085

8.  Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons.

Authors:  T A Good; D O Smith; R M Murphy
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

Review 9.  Upper extremity musculoskeletal manifestations of dialysis-associated amyloidosis.

Authors:  D C Fitzpatrick; P J Jebson; S M Madey; C M Steyers
Journal:  Iowa Orthop J       Date:  1996

10.  Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.

Authors:  P D Gorevic; P C Munoz; T T Casey; C R DiRaimondo; W J Stone; F C Prelli; M M Rodrigues; M D Poulik; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.